Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2024-08-07

Clinical Trial Update: Antiorbital Calcium in Chronic Conditions [NA]

View source ↗

Summary

The clinical trial evaluating Antiorbital Calcium for atrial fibrillation has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Antiorbital Calcium

Snippet

Sponsor: National University of Natural Medicine | Conditions: Atrial Fibrillation | NA | Status: WITHDRAWN